Skip to content

Proteomic Pattern Associated With the Diagnosis of Chronic Thromboembolic Pulmonary Hypertension

Proteomic Pattern Associated With the Diagnosis of Chronic Thromboembolic Pulmonary Hypertension : PROTEO-CTEPH Study.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05340023
Acronym
PROTEO-CTEPH
Enrollment
120
Registered
2022-04-21
Start date
2022-11-09
Completion date
2027-05-31
Last updated
2025-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Thromboembolic Pulmonary Hypertension

Keywords

Pulmonary hypertension;, chronic thromboembolic pulmonary hypertension, pulmonary embolism, proteomic pattern

Brief summary

Chronic ThromboEmbolic Pulmonary Hypertension (CTEPH) is a rare but severe complication of pulmonary embolism (PE). CTEPH is evoked in patients with persistent dyspnea. According to international guidelines, symptomatic patients with perfusion defects on lung scan and Pulmonary Hypertension (PH)-likely transthoracic echo (TTE) must be evaluated in Pulmonary Hypertension (PH)-centers with right heart catheterism, to confirm or rule out the presence of precapillary Pulmonary Hypertension (PH), and precise the group of Pulmonary Hypertension (PH).

Detailed description

However, persistent dyspnea and perfusion defects are frequent after pulmonary embolism (PE), and the accuracy of transthoracic echo (TTE) is not great for precapillary Pulmonary Hypertension (PH). This study proposed to seek for a specific proteomic pattern in patients admitted for a suspicion of Chronic ThromboEmbolic Pulmonary Hypertension (CTEPH).

Interventions

BIOLOGICALblood sample

to realize proteomic analysis.

Sponsors

Centre Hospitalier Universitaire de Saint Etienne
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient with a suspicion of Chronic thromboembolic pulmonary hypertension (CTEPH) with a combination of a perfusion lung scan and transthoracic perfusion scan and transthoracic echocardiography compatible with the diagnosis (according to French recommendations) * Patients who require a right heart catheterization. * Patient affiliated or entitled to a social security plan * Patient having received informed information about the study informed about the study

Exclusion criteria

* Patient with a normal perfusion lung scan * Person under legal guardianship

Design outcomes

Primary

MeasureTime frameDescription
Proteomic pattern associated with the diagnosis of Chronic thromboembolic pulmonary hypertension (CTEPH)Day: 0Analysis of the final diagnosis retained for the patient : Chronic thromboembolic pulmonary hypertension (CTEPH) (population of interest), pre-capillary Pulmonary Hypertension (PH) other than Chronic thromboembolic pulmonary hypertension (CTEPH), post-capillary Pulmonary Hypertension (PH), no Pulmonary Hypertension (PH).

Secondary

MeasureTime frameDescription
Analysis of recording of hemodynamic data at diagnosisDay: 0hemodynamic data : pulmonary vascular resistance, cardiac index, pulmonary arterial pressures
Analysis of recording of hemodynamic after 6 months of treatment6 monthshemodynamic data : pulmonary vascular resistance,
Analysis of recording of hemodynamic data at diagnosis and at death6 monthshemodynamic data : pulmonary arterial pressures

Countries

France

Contacts

Primary ContactLaurent BERTOLETTI, MD PhD
laurent.bertoletti@chu-st-etienne.fr(0)477127770
Backup ContactCarine LABRUYERE
carine.labruyere@chu-st-etienne.fr(0)477120826

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026